# Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD. – FDA Inspection, Mar 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/hangzhou-huadong-medicine-group-zhejiang-huayi-pharmaceutical-co-ltd/4651a11d-4232-48f5-840a-c7112616b42b
Source feed: FDA_Inspections

> FDA inspection 1050113 of Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD., March 16, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050113
- Company Name: Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD.
- Inspection Date: 2018-03-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1270219 - 2025-04-18](https://www.keypedia.com/records/fda_inspections/hangzhou-huadong-medicine-group-zhejiang-huayi-pharmaceutical-co-ltd/88d05dd1-9393-4d4e-a3fd-6100662a18a7)
- FDA Inspection 926970 - 2015-04-03
- FDA Inspection 706890 - 2010-10-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)

Company: https://www.keypedia.com/companies/hangzhou-huadong-medicine-group-zhejiang-huayi-pharmaceutical-co-ltd/4fcabfd2-d6e5-41ab-a543-fd9b939f8430

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
